ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

KTRA Kintara Therapeutics Inc

0,2061
-0,0099 (-4,58%)
Zuletzt aktualisiert: 15:54:12
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Kintara Therapeutics Inc KTRA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0099 -4,58% 0,2061 15:54:12
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,2051 0,19 0,2115 0,216
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
13.6.202422:10EDGAR2Form 425 - Prospectuses and communications, business..
13.6.202422:05EDGAR2Form 8-K - Current report
03.6.202414:50EDGAR2Form 425 - Prospectuses and communications, business..
03.6.202414:45EDGAR2Form 8-K - Current report
03.6.202414:35PRNUSTuHURA Biosciences and Kintara Therapeutics Announce..
17.5.202422:10EDGAR2Form ARS - Annual Report to Security Holders
17.5.202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
14.5.202422:55EDGAR2Form 425 - Prospectuses and communications, business..
14.5.202422:50EDGAR2Form 8-K - Current report
14.5.202422:45PRNUSKintara Therapeutics Announces Fiscal 2024 Third Quarter..
14.5.202422:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.5.202422:06EDGAR2Form S-4 - Registration of securities, business combinations
05.4.202419:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
03.4.202413:00PRNUSKintara Therapeutics and TuHURA Biosciences Enter into..
27.3.202414:00PRNUSKintara Therapeutics Announces Expansion of REM-001 Clinical..
27.2.202412:59EDGAR2Form 8-K - Current report
26.2.202413:00EDGAR2Form 8-K - Current report
22.2.202413:00EDGAR2Form 8-K - Current report
14.2.202422:07PRNUSKintara Therapeutics Announces Fiscal 2024 Second Quarter..
12.2.202415:05EDGAR2Form 8-K - Current report
12.2.202415:00PRNUSKintara Therapeutics Announces Initiation of REM-001..
18.12.202322:10EDGAR2Form 8-K - Current report
18.12.202322:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15.12.202322:15EDGAR2Form 8-K - Current report
07.12.202315:10EDGAR2Form 8-K - Current report
07.12.202315:00PRNUSKintara Therapeutics Announces Review of Strategic..
05.12.202315:10EDGAR2Form 8-K - Current report
05.12.202315:00PRNUSKintara Therapeutics Granted Extension by Nasdaq to Regain..
21.11.202313:55EDGAR2Form 8-K - Current report
13.11.202322:15EDGAR2Form 8-K - Current report
13.11.202322:10PRNUSKintara Therapeutics Announces Fiscal 2024 First Quarter..
13.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.10.202313:10EDGAR2Form 8-K - Current report
31.10.202313:00PRNUSKintara Therapeutics Announces Preliminary Topline Results..
27.10.202322:05EDGAR2Form S-1/A - General form for registration of securities..
24.10.202322:43EDGAR2Form S-1/A - General form for registration of securities..
10.10.202322:06EDGAR2Form 8-K - Current report
04.10.202322:35EDGAR2Form S-1 - General form for registration of securities under..
26.9.202322:09EDGAR2Form 8-K - Current report
21.9.202315:35GLOBEDawson James Securities Announces October Date for 8th..
19.9.202322:20EDGAR2Form 8-K - Current report
19.9.202322:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18.9.202322:31EDGAR2Form 8-K - Current report
18.9.202322:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11.9.202322:06EDGAR2Form DEF 14A - Other definitive proxy statements
02.9.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.9.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.9.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.9.202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
30.6.202323:11EDGAR2Form 8-K - Current report